Clinical trials

4 posts

  • Heterogeneous treatment effects and homogeneous outcome variances

    Recently there has been a couple of meta-analyses investigating heterogeneous treatment effects by analyzing the ratio of the outcome variances in the treatment and control group. The argument made in these articles is that if individuals differ in their response, then observed variances in the treatment and control group in RCTs should differ. In this post I explore this argument and provide a counterargument.

  • Mediation, confounding, and measurement error

    In this post, I give a brief simulation-based example of how confounding and measurement error impacts the estimation of direct and indirect effects in a mediation analysis.

  • Confounded dose-response effects of treatment adherence: fitting Bayesian instrumental variable models using brms

    Non-randomized comparisons are common in RCTs. In this post I show some examples of confounding and collider bias, using treatment adherence as an example. I present a small simulation study that show that common regression models used in clinical psychology, makes little sense, and that Bayesian instrumental variable regression can be easily fit using the R package brms.

  • Are the Current Criteria for Empirically Supported Treatments Too Lenient?

    The practice of classifying treatments as empirically supported has been widely debated for a long time. In this post I write about a recent article that raises several concerns and suggestions regarding the current use of EST criteria—which can be summarized as the current criteria being too lenient, something that I wholeheartedly agree with